Product Details

Trajenta

Linagliptin
5 mg
Tablet


DIN/PIN/NPN

02370921

Manufacturer

Boehringer-Ingelheim (Canada) Ltd./Ltee

Formulary Listing Date

2012-09-28  

Unit Price

2.6954

Amount MOH Pays

2.6954

Coverage Status

General Benefit Chronic-Use Medication Insulin or Oral Hypoglycemic Product

ODB Formulary Therapeutic Classification

Therapeutic Note

Linagliptin 5 mg Tablet: Treatment of Type 2 diabetes in patients on maximally tolerated doses of metformin who have: . Inadequate glycemic control (defined as HbA1c greater than 0.07) and intolerance or contraindication to a sulfonylurea; OR . Inadequate glycemic control (HbA1c greater than 0.07) and on maximal doses of a sulfonylurea and for whom insulin is not an option.

ATC Code

A10BH05

Interchangeable Products

NO  

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph